SVIP and prostate carcinoma: The expression of SVIP mRNA in tumor tissue was significantly higher than in normal tissue in most cancer types, including acute myeloid leukemia, breast, colon, liver, pancreas, thyroid, and prostate cancers (Figure 1A).